Characteristic attributes in cancer microarrays

被引:45
作者
Sarkar, IN
Planet, PJ
Bael, TE
Stanley, SE
Siddall, M
DeSalle, R
Figurski, DH
机构
[1] Amer Museum Nat Hist, Div Invertebrate Zool, New York, NY 10024 USA
[2] Columbia Univ Coll Phys & Surg, Dept Med Informat, New York, NY 10032 USA
[3] Columbia Univ Coll Phys & Surg, Dept Microbiol, New York, NY 10032 USA
[4] Columbia Presbyterian Med Ctr, Dept Internal Med, New York, NY 10032 USA
[5] Genaissance Pharmaceut, New Haven, CT 06511 USA
关键词
cladistics; expression profile; pattern recognition; T-cell; B-cell; melanoma; colon cancer; ALL; AML;
D O I
10.1016/S1532-0464(02)00504-X
中图分类号
TP39 [计算机的应用];
学科分类号
081203 ; 0835 ;
摘要
Rapid advances in genome sequencing and gene expression microarray technologies are providing unprecedented opportunities to identify specific genes involved in complex biological processes, such as development, signal transduction, and disease. The vast amount of data generated by these technologies has presented new challenges in bioinformatics. To help organize and interpret microarray data, new and efficient computational methods are needed to: (1) distinguish accurately between different biological or clinical categories (e.g., malignant vs. benign), and (2) identify specific genes that play a role in determining those categories. Here we present a novel and simple method that exhaustively scans microarray data for unambiguous gene expression patterns. Such patterns of data can be used as the basis for classification into biological or clinical categories. The method, termed the Characteristic Attribute Organization System (CAOS), is derived from fundamental precepts in systematic biology. In CAOS we define two types of characteristic attributes ('pure' and 'private') that may exist in gene expression microarray data. We also consider additional attributes ('compound') that are composed of expression states of more than one gene that are not characteristic on their own. CAOS was tested on three well-known cancer DNA microarray data sets for its ability to classify new microarray samples. We found CAOS to be a highly accurate and robust class prediction technique. In addition, CAOS identified specific genes, not emphasized in other analyses, that may be crucial to the biology of certain types of cancer. The success of CAOS in this study has significant implications for basic research and the future development of reliable methods for clinical diagnostic tools. (C) 2002 Elsevier Science (USA). All rights reserved.
引用
收藏
页码:111 / 122
页数:12
相关论文
共 52 条
[31]   AMPLIFICATION OF A C-YES-1-RELATED ONCOGENE IN CANINE LYMPHOID LEUKEMIA [J].
MINA, RB ;
TATEYAMA, S ;
MIYOSHI, N ;
UCHIDA, K ;
YAMAGUCHI, R ;
OHTSUKA, H .
JOURNAL OF VETERINARY MEDICAL SCIENCE, 1994, 56 (04) :773-774
[32]   NEURAL CELL-ADHESION MOLECULE-DISTRIBUTION IN PRIMARY AND METOSTATIC UVEAL MELANOMA [J].
MOOY, CM ;
LUYTEN, GPM ;
DEJONG, PTVM ;
JENSEN, OA ;
LUIDER, TM ;
VANDERHAM, F ;
BOSMAN, FT .
HUMAN PATHOLOGY, 1995, 26 (11) :1185-1190
[33]   Effect of endogenous interleukin-6 on Fas (APO-1/CD95) receptor expression in advanced melanoma patients [J].
Mouawad, R ;
Antoine, EC ;
Khayat, D ;
Soubrane, C .
CYTOKINES CELLULAR & MOLECULAR THERAPY, 2000, 6 (03) :135-140
[34]   C-YES AND BC1-2 GENES LOCATED ON 18Q21.3 IN A FOLLICULAR LYMPHOMA CELL-LINE CARRYING A T(14 - 18) CHROMOSOMAL TRANSLOCATION [J].
OHNO, H ;
FUKUHARA, S ;
TAKAHASHI, R ;
MIHARA, K ;
SUGIYAMA, T ;
DOI, S ;
UCHINO, H ;
TOYOSHIMA, K .
INTERNATIONAL JOURNAL OF CANCER, 1987, 39 (06) :785-788
[35]   E-SERIES PROSTAGLANDINS ARE POTENT GROWTH-INHIBITORS FOR SOME B-LYMPHOMAS [J].
PHIPPS, RP ;
LEE, D ;
SCHAD, V ;
WARNER, GL .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1989, 19 (06) :995-1001
[36]   Systematic analysis of DNA microarray data: Ordering and interpreting patterns of gene expression [J].
Planet, PJ ;
DeSalle, R ;
Siddall, M ;
Bael, T ;
Sarkar, IN ;
Stanley, SE .
GENOME RESEARCH, 2001, 11 (07) :1149-1155
[37]  
Raychaudhuri S, 2000, Pac Symp Biocomput, P455
[38]   The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma [J].
Rosenwald, A ;
Wright, G ;
Chan, WC ;
Connors, JM ;
Campo, E ;
Fisher, RI ;
Gascoyne, RD ;
Muller-Hermelink, HK ;
Smeland, EB ;
Staudt, LM .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (25) :1937-1947
[39]   SELECTIVE PRESERVATION OF PROTEIN-KINASE C-ZETA IN THE CHEMOPREVENTION OF AZOXYMETHANE-INDUCED COLONIC TUMORS BY PIROXICAM [J].
ROY, HK ;
BISSONNETTE, M ;
FRAWLEY, BP ;
WALI, RK ;
NIEDZIELA, SM ;
EARNEST, D ;
BRASITUS, TA .
FEBS LETTERS, 1995, 366 (2-3) :143-145
[40]  
Sanders DSA, 2000, J PATHOL, V190, P526, DOI 10.1002/(SICI)1096-9896(200004)190:5<526::AID-PATH564>3.0.CO